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Abstract
Block ionomer complex (BIC)-siRNA interactions and effectiveness in cell transfection are 
reported. Aqueous RAFT polymerization was used to prepare a series of hydrophilic-block-
cationic copolymers in which the cationic block statistically incorporates increasing amounts of 
neutral, hydrophilic monomer such that the number of cationic groups remains unchanged but the 
cationic charge density is diluted along the polymer backbone. Reduced charge density decreases 
the electrostatic binding strength between copolymers and siRNA with the goal of improving 
siRNA release after targeted cellular delivery. However, lower binding strength resulted in 
decreased transfection and RNA interference pathway activation, leading to reduced gene 
knockdown. Enzymatic siRNA degradation studies with BICs indicated lowered binding strength 
increases susceptibility to RNases, which is the likely cause for poor gene knockdown.
Introduction
RNA interference (RNAi) triggers post-transcriptional gene suppression via sequence-
specific recognition and destruction of cellular transcripts.1 “Gene knockdown” is achieved 
through delivery of synthetic small interfering RNA (siRNA), which can be designed to 
target the gene of interest,2–5 making RNAi appealing for gene therapeutics. However, RNA 
delivery vehicles must overcome a number of barriers, including target specificity and 
vehicle cytotoxocity.5
Polymeric vectors can provide both enhanced stability and decreased immunogenic response 
relative to more traditional vectors (e.g. viral and lipid-based).3 Of particular interest are 
polycationic polymers that electrostatically complex the negatively-charged RNA 
†Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here].
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phosphodiester backbone to form interpolyelectrolyte complexes (IPECs).6,7 Such IPECs are 
often characterized by the molar ratio of cationic functionalities (e.g. amines) to 
phosphodiester units, termed the nitrogen-to-phosphate ratio (N:P). Non-stoichiometric 
IPECs from cationic homopolymers have been extensively studied and provide enhanced 
protection from enzymatic degradation while maintaining complex hydrophilicity.3,8 
However, the excess charges required to maintain solubility result in adverse effects: 
negatively-charged complexes (N:P < 1) suffer from decreased transfection due to 
electrostatic repulsion at the negatively-charged cellular membrane, and positively-charged 
complexes (N:P > 1) result in increased cytotoxity and opsonization within the blood stream, 
leading to higher immune response.6,9–11 Block copolymers consisting of a cationic block 
and a non-ionic, hydrophilic block can form stoichiometric, neutrally charged IPECs with 
RNAs while maintaining complex hydrophilicity. These so-called block ionomer complexes 
(BICs) exhibit both decreased cytotoxicity and enhanced stability,7,12 and incorporation of 
cellular targeting moieties within their hydrophilic, corona-forming blocks results in cell-
specific siRNA delivery.8,13
Our research group has maintained a strong interest in the rational design and synthesis of 
drug delivery systems utilizing aqueous RAFT (aRAFT) polymerization targeting 
controlled, tailored (co)polymers for stimuli-responsive micelles,14–16 theranostics,17 
peptide mimics,18 modular copolymers,19,20 and vehicles for endosomal escape.21 Our most 
recent efforts have focused on the development of siRNA-containing BICs for cell-specific 
delivery as well as determining the effect of aRAFT copolymer architecture on siRNA 
delivery efficacy. Previously, we demonstrated targeted cellular delivery and subsequent 
gene knockdown using BICs formed between siRNA and hydrophilic-block-cationic 
copolymers.13 Furthermore, we observed a correlation between cationic block length and 
siRNA stabilization as well as gene knockdown efficacy: longer cationic block lengths 
resulted in increasingly enhanced siRNA stability as well as longer time periods required to 
achieve maximum gene knockdown in vitro.22 We attributed delayed gene suppression to 
slow release of the siRNA from the complexes, presumably via macromolecular exchange. 
This correlates well with other groups’ findings that enhanced complexation and stability in 
plasmid DNA (pDNA) delivery result in inefficient DNA release, indicating that 
intermediate binding and stability is desireable.23–25 Such intermediacy is likely achievable 
via alteration of the cationic charge density. Indeed, IPECs formed from polymers with 
varying degrees of cationic quaternization yield higher pDNA transfection efficiency and 
expression at moderate charge densities as compared to linear polycations.24,25 However, 
variable charge density has not been studied in BICs, specifically those containing siRNA.
In this study, we report the synthesis of a series of hydrophilic-block-cationic copolymers 
via aRAFT polymerization in which the cationic block statistically incorporates increasing 
amounts of neutral, hydrophilic monomer such that the number of cationic groups remains 
unchanged but the cationic charge density is diluted along the polymer backbone. These 
polymers were subsequently complexed with siRNA and siRNA analogs. To our knowledge, 
this is the first study directed toward elucidating the effect of cationic block charge density 
on BIC binding strength/stability and siRNA delivery. siRNA stability and BIC binding 
strength were evaluated utilizing solution differential scanning calorimetry (DSC) and 
potentiometric titration respectively, and cellular siRNA delivery experiments were 
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performed to correlate those results with gene knockdown efficacy. Herein, we demonstrate 
reduced siRNA stability, binding strength, and gene knockdown with decreasing cationic 
block charge density. We correlate these trends to reduced siRNA delivery and uptake within 
the RNAi pathway, which suggests greater siRNA vulnerability to enzymatic degradation. 
Indeed, we confirm higher rates of enzymatic hydrolysis with reduced cationic charge 
density by establishing RNase degradation kinetic profiles. We conclude that while reduced 
binding strength results in more rapid siRNA release via macromolecular exchange, such 
facile exchange increases the likelihood of degradation prior to activation of the RNAi 
pathway.
Results and Discussion
Synthesis of hydrophilic-block-cationic copolymers with varying cationic block charge 
density
Based upon our previous observation that decreasing cationic block length reduces the time 
required to achieve maximum gene knockdown,22 we reasoned that reduced cationic block 
charge density should decrease BIC binding strength, facilitating the release of siRNA from 
the complexes via more rapid macromolecular exchange.
We therefore synthesized hydrophilic-block-cationic copolymers with varying cationic block 
charge density (Scheme 1). The first step was accomplished using aRAFT to prepare a 
statistical macroCTA consisting of an initial monomer feed ratio of 95 mol % N-(2-
hydroxypropyl)methacrylamide (HPMA) and 5 mol % N-(3-aminopropyl)methacrylamide 
(APMA) in 1 M acetate buffer (pH = 4.5) at 70 °C using 4-cyano-4-
[(ethylsulfanylthiocarbonyl)sulfanyl]pentanoic acid (CEP) as the CTA and 4,4’-
azobiscyanovaleric acid (V-501) as the initiator. HPMA contributes non-ionic hydrophilicity 
to the copolymer, and is known to be non-immunogenic,26 promoting greater 
biocompatibility. Incorporation of the primary amine functionality of APMA provides a 
convenient handle for the conjugation of the cellular-targeting moiety folic acid. 1H NMR 
analysis revealed a final copolymer composition of 97 mol % HPMA and 3 mol % APMA, 
which closely matches the monomer feed ratio.
The resulting poly(HPMA226-stat-APMA7) macroCTA was subsequently subjected to a 
series of chain extensions with both HPMA and N-[3-
(dimethylamino)propyl]methacrylamide (DMAPMA), targeting DMAPMA monomer molar 
feeds, and thus charge densities, of 100% (P100), 75% (P75), 50% (P50), 25% (P25), and 
0% (P0)‡. The tertiary amines of DMAPMA provide cationic sites under physiological 
conditions (pH = ~7.4) for complexation with the negatively-charged siRNA backbone. 
Additionally, the statistical incorporation of HPMA within the cationic block allows for 
increased spacing of the cationic groups, and thus lower charge density, along the polymer 
backbone while minimizing inter- and intramolecular hydrophobic interactions of the 
copolymers. ASEC-MALLS chromatograms for the macroCTA and the chain extensions are 
shown in Figure 1, and the relevant polymer characterization data are summarized in Table 
‡Discussion of experiments relating to control polymer P0 can be found in the ESI†.
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1. Shifts to lower elution volume while maintaining low dispersities (Ð < 1.2) indicate 
successful chain extension, and 1H NMR analysis revealed block compositions (block A: 
HPMA-stat-APMA; block B: HPMA-stat-DMAPMA) closely matching the monomer feed 
ratios. Cationic block charge densities are reported as molar percentages of DMAPMA 
within block B.
The post-polymerization modification of APMA units with folic acid, which our group has 
previously demonstrated to function well as a cell-specific targeting moiety,13 was 
monitored via UV-Vis spectroscopy (ESI† Figure S2). Based on an average extinction 
coefficient for free folic acid at pH = 7.4, approximately 4 of 7 possible APMA units per 
polymer were successfully labelled. This extent of folic acid conjugation, combined with 
low APMA molar content, resulted in hydrophilic-block-cationic copolymers capable of 
electrostatically complexing with oligonucleotides through the DMAPMA tertiary amines of 
cationic block B, while the hydrophilic, cellular-targeting block A maintains BIC solubility. 
Thus, oligonucleotide complexation with these well-defined hydrophilic-block-cationic 
copolymers with varying charge density allows for correlation of cationic block charge 
density to BIC complexation strength and in vitro gene knockdown.
Hydrophilic-block-cationic copolymers with varying charge density form stable, neutrally-
charged complexes
Having successfully synthesized a series of hydrophilic-block-cationic copolymers with 
varying cationic block charge density, we used dynamic light scattering (DLS) and ζ-
potential measurements to confirm their ability to complex siRNA while maintaining charge 
neutrality at N:P = 1. Table 2 presents the hydrodynamic radius (Rh) and ζ-potential of each 
copolymer-siRNA complex. The siRNA-containing BICs exhibited an average Rh of 9.6 nm, 
a value consistent with previously reported complexes of similar cationic content.13 
Copolymer solutions free of siRNA did not exhibit any particles visible by DLS (data not 
shown), indicating that the observed hydrodynamic radii indeed result from complex 
formation rather than copolymer aggregation. The near-zero ζ-potential values confirm 
complex charge neutrality, targeted for preventing cytotoxicity. The amount of polymer-
complexed siRNA was quantified using the Agilent Bioanalyzer platform 
(electropherograms in ESI† Figure S6), and copolymers P25-P100 complexed 
approximately 76% of available siRNA, which is comparable to our previous report.27
Reduced cationic block charge density decreases oligonucleotide stabilization
Relative oligonucleotide stability can be determined by elucidating the melting temperature 
(Tm), i.e. the temperature at which the double-stranded duplex separates into its single-
stranded components. An increase in Tm, which is manifested as an endotherm maximum in 
the DSC thermogram, is indicative of increased duplex stability.28
Previous work in our laboratories used dsDNA as an analog to siRNA in order to ascertain 
the effect of cationic block length of the copolymer on oligonucleotide stability.22 In the 
present study, we used samples P0-P100 to prepare BICs with dsDNA, and the respective 
DSC thermograms are shown in Figure 2. Complexation results in increased Tm over that of 
free dsDNA (Tm = 54.4 °C).22 Generally, Tm decreases with decreasing cationic block 
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charge density (P75, 83.3 °C > P50, 81.3 °C > P25, 75.0 °C). Although P100 has a 
continuous (i.e. no neutral comonomer) cationic block, its actual number of charges (14 
DMAPMA units) is lower than for polymers P25-P75 (~20 DMAPMA units), resulting in a 
Tm = 81.0 °C. However, BICs formed with previously reported (HPMA171-stat-APMA13)-
block-DMAPMA27 (P2), which has a longer continuous cationic block, exhibit a dsDNA Tm 
value of 88.4 °C.22 Therefore, we may conclude that the enhanced oligonucleotide stability 
afforded by complexation decreases as cationic block charge density decreases.
Reduced cationic block charge density reduces complex binding strength
Having confirmed that reduced charge density diminishes the oligonucleotide-stabilizing 
effect of complexation, we next sought to demonstrate that it similarly reduces BIC binding 
strength as characterized by the free energy of complex formation. The cationic nature of 
weak polyelectrolytes, such as those containing DMAPMA, is due to the pH-dependent 
protonation of the amine functionalities and thus can be monitored via potentiometric acid-
base titration. From the potentiometric titrations of a polyelectrolyte and its corresponding 
IPEC, one can obtain the degrees of protonation (α, fraction of protonated amines) and 
complexation (θ, fraction of ionic complex pairs out of total possible pairs) respectively. 
Kabanov and co-workers7 have demonstrated that for IPECs consisting of a weak 
polyelectrolyte (e.g. PDMAPMA) and a strong polyelectrolyte (e.g. siRNA), all of the 
protonated units of the weak polycation will form ionic pairs with a strong polyanion 
functionality, i.e. α = θ. Due to the cooperativity of IPEC formation, a shift (ΔpH(α)) 
occurs in the θ vs. pH curve of an IPEC relative to the α vs. pH curve of the corresponding 
free polycation (Figure 3A). The free energy of complex formation (ΔGtotal) as a function of 
α, where α = α1 (= θ1), is given by the following:7
Evaluation of the binding strength of oligonucleotide-containing BICs by potentiometric 
titration is complicated by the pH-dependent protonation of DNA and RNA bases. Thus, in 
this study we have adopted an approach similar to that of Lee et al.29 who used polystyrene 
sulfonate (PSS) as a strong polyanion analog that does not affect the titration curve over the 
pH range investigated. We selected PSS with low molecular weight (Mn = 16 kDa, DP ≈ 69) 
such that the number of anionic charges is similar to that of duplex siRNA (59 nucleotides).
Figure 3 depicts the α- and θ vs. pH curves for P0-P100 and lists the free energies of 
complexation for copolymer-PSS BICs. In general, the magnitude of free energy decreases 
with decreasing cationic block charge density (P75, −3.28 kJ/mol; P50, −2.42 kJ/mol; P25, 
−1.35 kJ/mol). Consistent with the DSC experiments in the previous section, despite being a 
continuous cationic block, the fewer number of charges in P100 relative to P25-P75 results 
in a lower binding strength with a ΔGtotal value of −2.61 kJ/mol. However, titration of 
(HPMA171-stat-APMA13)-block-DMAPMA27 (P2)22 with a longer continuous cationic 
block length yields a ΔGtotal value of −4.4 kJ/mol. Thus, we may conclude that binding 
strength decreases with reduced cationic charge density.
Parsons et al. Page 5
Polym Chem. Author manuscript; available in PMC 2017 October 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Reduced charge density diminishes gene knockdown efficacy
Based on the trends of decreasing oligonucleotide stabilization and BIC binding strength 
with decreasing cationic block charge density, one would expect that decreased charge 
density would lead to greater bioavailability of the siRNA within cells via more rapid release 
and, therefore, enhanced gene knockdown. However, experimental results were opposite of 
this expectation. Figure 4A depicts the relative survivin mRNA levels 24 hours after 
treatment with copolymer-siRNA BICs. P100 and P75 copolymers resulted in 2- and 3-fold 
mRNA expression, respectively, relative to the Lipofectamine positive control. However, 
polymers with charge density less than 75% exhibited no decrease in survivin mRNA levels 
relative to the untreated negative control. Although diminished gene knockdown with 
reduced charge density is the opposite of the expected trend, these results are likely the 
result of more rapid macromolecular exchange due to reduced binding strength: rapid 
exchange with extra- and intracellular proteins results in reduced cellular delivery of siRNA 
and increased susceptibility to degradation by RNases (vide infra).
Cellular delivery and RNAi pathway activation decrease with reduced cationic block 
charge density
To determine the relative cellular loading of siRNA by each polymer, cells were treated with 
copolymer-(fluorescently-labelled siRNA) BICs and were subsequently imaged via confocal 
fluorescence microscopy (images in ESI† Figure S5). The corrected total fluorescence 
(CTF) of representative areas for each treated cell culture is depicted in Figure 4B, and 
decreasing cellular siRNA content was observed with decreasing cationic block charge 
density. Furthermore, statistical analysis of CTF revealed a significant decrease in siRNA 
content between P75 and P50, which corresponds well to lack of gene knockdown for 
copolymers with charge density < 75%. Because siRNA release must result from a 
macromolecular exchange reaction rather than spontaneous dissociation,7 the decreased 
cellular delivery must be the result of exchange reactions with biomacromolecules in the 
extracellular media. However, P50 and P25 successfully delivered moderate amounts of 
siRNA, yet no gene knockdown was observed, suggesting reduced siRNA participation in 
the RNAi pathway.
Quantification of protein-bound siRNA within the cells serves as an indication of the level of 
RNAi activity. Because the threshold in cationic block charge density required for successful 
gene knockdown lies between P75 and P50, these copolymers were used to deliver radio-
labelled siRNA, and the treated cells were subjected to cellular fractionation via sucrose 
density gradients. The fractions were then subjected to PAGE, followed by electroblotting to 
quantify the relative amounts of radio-labelled siRNA in each, depicted in Figure 4C. Higher 
fraction numbers correspond to increased gradient density; therefore, farther migration of 
siRNA into the heavier fractions is indicative of siRNA-protein complexes (i.e. siRNA entry 
into the RNAi pathway). siRNA levels have been normalized to fraction 1 (i.e. protein-free 
siRNA) for each cell culture. P75 complexes resulted in a greater amount of protein-
complexed siRNA relative to its protein-free siRNA than did P50, indicating that, in addition 
to increased cellular siRNA concentration, P75 complexes resulted in a greater percentage of 
that siRNA participating in RNAi. Therefore, as cationic block charge density decreases, 
less siRNA is trafficked into the cells, and even less RNAi activation is achieved.
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When taken in conjunction, the fluorescence microscopy and cell fractionation results 
suggest that instead of increasing siRNA bioavailability, decreasing cationic block charge 
density leaves the siRNA more vulnerable to enzymatic degradation by RNases within the 
cell culture media and within the cells themselves. Reineke and coworkers30 reported similar 
results utilizing hydrophilic-stat-cationic and hydrophilic-block-cationic copolymers to 
deliver luciferase-expressing plasmid DNA (pDNA): statistical copolymerization of their 
tertiary amine-containing monomer resulted in decreased luciferase expression relative to 
the block copolymer. The authors suggested that statistical copolymerization may have 
resulted in more rapid complex dissociation and thus inefficient trafficking of the pDNA to 
the nucleus. Our demonstration of decreased BIC binding strength with lower charge 
density, along with diminishing siRNA delivery and RNAi activation, corroborates their 
conclusion: weaker binding likely results in more rapid macromolecular exchange with 
cellular proteins like RNases.
Enzymatic degradation rates increase as cationic block charge density decreases
Although siRNA degradation within cells cannot be directly observed, circular dichroism 
(CD) spectroscopy can be used to monitor the degradation kinetics of siRNA by RNases in 
vitro. The characteristic CD spectrum peaks of siRNA result from its secondary structure,31 
and thus we monitored the molar ellipticity at 212 nm ([θ]212) as the siRNA was hydrolyzed 
along its phosphodiester backbone by Riboshredder RNase blend (Figure 5A). Figure 5B 
depicts normalized [θ]212 of siRNA and copolymer-siRNA complexes as a function of time. 
Based upon the gene knockdown, cellular loading, and cell fractionation experiments, we 
expected to see an increase in the rate of degradation with decreasing cationic block charge 
density. Indeed the decay rate of [θ]212 increases from P100 to P0, indicating that decreased 
charge density does result in decreased protection from enzymatic degradation. This notion 
is in good agreement with the decreased oligonucleotide stabilization and binding strength, 
determined via solution DSC and potentiometric titration respectively, as a function of 
decreasing charge density.
Conclusions
The aRAFT polymerization of hydrophilic-block-cationic copolymers with varying cationic 
block charge densities and their subsequent complexation with siRNA and siRNA analogs 
has been demonstrated. Reduced charge density in these BICs resulted in lower 
oligonucleotide stabilization and binding strength, characteristics that predict more rapid 
siRNA release and thus enhanced gene suppression. However, decreased cellular 
transfection and RNAi activation, which resulted in decreased gene knockdown, indicate that 
decreased binding strength afforded by reduced charge density promotes greater 
susceptibility to enzymatic degradation. Indeed the higher rate of in vitro RNase degradation 
with decreasing charge density supports this notion. Components of the RNAi pathway 
likely have a higher affinity for siRNA than do other RNA-binding proteins (e.g. RNases). 
Thus, they likely are able to extricate siRNAs from higher charge density copolymers, 
whereas less specific RNases cannot.
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These results indicate that for hydrophilic-block-cationic copolymers with relatively few 
charges (i.e. ~20 DMAPMA units), siRNA delivery is most effective utilizing a fully 
charged cationic block without non-ionic comonomer. However, it is worth noting that 
decreasing cationic block charge density diminishes copolymer cytotoxicity (ESI† Figure 
S6). Thus, application of variable charge density to block copolymers with a greater number 
of DMAPMA units should improve polymer biocompatibility while providing sufficient 
number of cations to maintain siRNA protection. The effect of cationic block charge density 
in copolymers with greater cationic content is the subject of ongoing investigation.
Experimental
Materials
All reagents were purchased from Sigma and used as received unless otherwise noted. 4,4’-
Azobiscyanovaleric acid (V-501) was purchased from Wako and was recrystallized twice 
from methanol. Azobisisobutyronitrile (AIBN) was recrystallized from methanol. N-(3-
aminopropyl)methacrylamide hydrochloride (APMA) was purchased from Polysciences. N-
[3-(dimethylamino)propyl]methacrylamide (DMAPMA) and triethylamine (TEA) were 
distilled prior to use. 4-cyano-4-[(ethylsulfanylthiocarbonyl)sulfanyl]pentanoic acid 
(CEP),32 di-N-hydroxysuccinimide-activated folic acid (diNHS-FA),13 and N-(2-
hydroxypropyl)methacrylamide (HPMA)33 were synthesized according to literature 
procedures. Sodium polystyrene sulfonate (PSS) (Mn = 14.2 kDa, Ð = 1.13) was purchased 
from Scientific Polymer Products. HPLC purified oligonucleotides (siRNA against human 
survivin; unlabelled and AlexaFluor594-labeled, pre-diced siRNA; and oligomeric dsDNA) 
were purchased from Integrated DNA Technologies, Inc. The siRNA sequences targeting 
human survivin are as follows: Sense strand 5′-
AGCCCUUUCUCAAGGACCACCGCAUCU-3′ and the antisense strand 3′-
UUUCGGGAAAGAGUUCCUGGUGGCGUAGAGGA-5′. The pre-diced siRNA 
sequences are as follows: Sense strand 5’-GCUGGACUCCUUCAUCAACdTdT-3’ and the 
antisense strand 3’-dTdTCGACCUGAGGAAGUAGUUG-5’ (“dT” indicates deoxythiamine 
DNA base). The dsDNA sequences are as follows: Sense strand 5’-
AGATGTGCAATTTTGCTACCGCATCT-3’ and the antisense strand 5’-
AGGAGATGCGGTAGCAAAAGTTGCACATCTTT-3’. Oligonucelotides (siRNA and 
dsDNA) were heated at 95 °C for 10 min and were allowed to slowly cool to room 
temperature prior to use. Concentrations of oligonucleotide (siRNA and dsDNA) are 
reported as duplex concentrations unless otherwise noted. Gibco® RPMI 1640 cell culture 
media (with and without folic acid) and fetal bovine serum (FBS) were purchased from Life 
Technologies Corporation. KB cells were purchased from ATCC. For reactions requiring 
nitrogen, ultrahigh purity nitrogen (purity ≥ 99.998%) was used. Spectra/Por® regenerated 
cellulose dialysis membranes (Spectrum Laboratories, Inc) with a molecular weight cut-off 
of 12–14 kDa were used for dialysis.
Polymer Synthesis
Synthesis of poly(HPMA-stat-APMA) macroCTA—The macro chain transfer agent 
(macroCTA) was prepared employing V-501 as the primary radical source and CEP as the 
chain transfer agent at 70 °C. HPMA (12.61 g, 95.1 mmol) and APMA (894 mg, 5.0 mmol) 
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were added to a 250 ml round-bottomed flask and dissolved in 1 M acetate buffer (pH = 4.5) 
with a final volume of 100 ml ([M]0 = 1 M). The initial feed composition was 95 mol % 
HPMA and 5 mol % APMA. The round-bottomed flask was septum-sealed and purged with 
nitrogen for 1 hour prior to polymerization. The macroCTA was prepared with a [M]0/[CTA] 
ratio = 400 while the [CTA]/[I] ratio was kept at 5, and the reaction was allowed to proceed 
for 5 h. The polymerization was quenched by rapid cooling in liquid nitrogen followed by 
exposure to air. The macroCTA was isolated by dialysis (pH = 3–4) at 4 °C and recovered by 
lyophilization.
Synthesis of poly[(HPMA-stat-APMA)-block-(HPMA-stat-DMAPMA)] 
copolymers (P100, P75, P50, P25, and P0)—The poly(HPMA-stat-APMA) 
macroCTA was chain extended with HPMA and/or DMAPMA using V-501 as the primary 
radical source at 70 °C. The macroCTA, HPMA, and DMAPMA were dissolved in acetate 
buffer to give a total [M]0 = 1 M. The HPMA and DMAPMA initial feed compositions were 
adjusted to 100 mol % DMAPMA (P100); 75 mol % DMAPMA and 25 mol % HPMA 
(P75); 50 mol % DMAPMA and 50 mol % HPMA (P50); 25 mol % DMAPMA and 75 mol 
% HPMA (P25); and 100 mol % HPMA (P0). The round-bottomed flask was septum-sealed 
and subsequently purged with nitrogen for 1 h prior to polymerization. Block copolymers 
were prepared with [M]0/[CTA] = 200 while [CTA]/[I] was kept at 5. Each polymerization 
was terminated at predetermined time intervals by rapid cooling in liquid nitrogen and 
subsequent exposure to air. The poly[(HPMA-stat-APMA)-block-(HPMA-stat-DMAPMA)] 
copolymers were purified by dialysis (pH = 3–4) at 4 °C and recovered by lyophilization.
Block copolymer end-groups were removed via a standard literature procedure.34 A typical 
reaction is as follows: poly[(HPMA226-stat-APMA7)-block-DMAPMA14] (P100) (575 mg, 
14.3 µmol) was added to a 25 ml round-bottomed flask and dissolved in 6 ml of DMF. AIBN 
(70.4 mg, 0.429 mmol) was then added to the flask resulting in an AIBN/copolymer ratio of 
30:1. The solution was then septum-sealed, purged with nitrogen for 1 h, and allowed to 
react at 70 °C for 4 h. The resulting copolymer was precipitated from DMF into cold 
anhydrous diethyl ether three times.
Copolymer functionalization with folic acid
DiNHS-FA was prepared following a slightly modified literature prcedure.13 Briefly, folic 
acid (1.00 g, 2.3 mmol), NHS (1.30 g, 11.3 mmol), DCC (4.68 g, 22.7 mmol), and DMAP 
(277.5 mg, 2.3 mmol) were dissolved in 15 ml DMSO and stirred in the dark at room 
temperature for 24 h. The dicyclohexylurea precipitate was filtered off and the resulting 
solution was used without further purification.
The aforementioned diNHS-FA solution was then used to label the primary amine moieties 
of the APMA units in the chain-terminated block copolymers. A typical reaction is as 
follows: 49.5 mg (1.23 µmol) P100 was dissolved in 1 ml DMSO along with 5 µL TEA to 
serve as a catalyst. 1.53 ml of the diNHS-FA solution was added dropwise and the resulting 
solution was stirred in the dark at room temperature for 48 h. The reaction was quenched by 
the addition of excess ammonium hydroxide (100% by volume), and this reaction was 
carried out for 24 h. The resulting solution was then dialyzed against 0.6 M NaCl for 24 h, 
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followed by dialysis against DI water for 3 days. The polymer was recovered via 
lyophilization.
Formation of hydrophilic-block-cationic/oligonucleotide complexes
Preparation of copolymer-dsDNA complexes for solution differential scanning 
calorimetry—Poly[(HPMA-stat-APMA)-block-(HPMA-stat-DMAPMA)]-dsDNA 
complexes were prepared with N:P = 1 (i.e. neutral complexes). The dsDNA duplex 
concentration was maintained at 75 µM for all complexes. A typical preparation is as 
follows: 177 µL of a 1.785 mM poly[(HPMA226-stat-APMA7)-block-DMAPMA14] (P100) 
stock solution was added to 375 µL of a 200 µM dsDNA stock. The solution was diluted 
with 448 µL sodium cacadylate buffer, and the resulting dsDNA-copolymer complex 
solution was vortexed and equilibrated for 30 min. After equilibration, the solution was 
degassed for 30 min prior to DSC measurements. The dsDNA and polymer stock solutions 
were prepared in 10 mM sodium cacadylate buffer at pH 7.2.
Preparation of copolymer-siRNA complexes for gene suppression—Folic acid-
labelled poly[(HPMA-stat-APMA)-block-(HPMA-stat-DMAPMA)]-siRNA complexes were 
prepared with N:P = 1, and the siRNA concentration was maintained at 100 nM. A typical 
preparation is as follows: 2.8 µL of a 71.43 µM P100 stock solution was added to 3.3 µL of a 
20 µM siRNA stock solution. The complex solution was gently mixed and equilibrated for 
20 minutes prior to dilution with 214 µL folate- and serum-free RPMI, followed by gentile 
mixing. The siRNA and polymer stock solutions were prepared in 10 mM phosphate buffer 
(pH = 7.4).
Cell Culture
KB cells were maintained and proliferated in RPMI 1640 (with folic acid) supplemented 
with 10% FBS at 37 °C in 95% air humidified atmosphere and 5% CO2.
Gene Suppression of Human Survivin
24 hours prior to treatment, the KB cell medium was replaced with folic acid-free RPMI 
1640 supplemented with 10% FBS. Cells (200,000 cells/mL, 500 µL) were seeded in a 48 
well plate (Corning Inc.). Cells were treated with 50 µL of a polymer-siRNA complex 
solution. Lipofectamine 2000 (Invitrogen) was used as the positive control, and the 
Lipofectamine-siRNA complexes were prepared according to manufacturer protocol. The 
final siRNA concentration delivered was maintained at 100 nM. After 24 hours, total RNA 
was extracted with TriZol (Invitrogen) following manufacturer protocol. Survivin transcript 
abundance was determined using RT-qPCR. First strand cDNA was synthesized with the 
Reverse Transcription Kit (Fermentas). Amplification and quantification was carried out 
with a 2X qPCR mix containing SYBR green (Fisher Scientific) and a BioRad CFX 96. The 
primer pairs for detecting the survivin gene were 5′-AGCCCTTTCTCAAGGACCAC and 
5′-TCCTCTATGGGGTCGTCATC. PCR primers for β-Actin gene were 5′-
CATGTACGTTGCTATCCAGGC and 5′-CTCCTTAATGTCACGCACGAT.
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Fluorescence Microscopy
24 hours prior to treatment, the KB cell medium was replaced with folic acid-free RPMI 
1640 supplemented with 10% FBS. Cells (200,000 cells/mL, 2 mL) were seeded on cover 
glasses in a 6 well plate (Corning Inc.). Cells were treated with 500 µL of a polymer-siRNA 
(siRNA tagged with AlexaFluor594) complex solution. Lipofectamine 2000 (Invitrogen) 
was used as the positive control, and the Lipofectamine-siRNA complexes were prepared 
according to manufacturer protocol. The final siRNA concentration delivered was 
maintained at 100 nM. After 24 hours, the cells were fixed with 4% formaldehyde and 
washed with PBS prior to imaging. The cells were then stained with 12 µL of 4’,6-
diamidino-2-phenylindole (DAPI) mounting medium. The cover glasses were then placed on 
precleaned microscope slides for analysis. Fluorescence cell images were taken using a 
Zeiss LSM 510 scanning confocal microscope and processed with manufacturer software. 
Multiple fields were examined for each sample to ensure uniform distribution of complexes 
throughout. Representative areas were selected in quadruplicate, the fluorescence intensities 
were determined in ImageJ, and the corrected total fluorescence (CTF) of each area was 
calculated according to the relation
Statistical variance between samples was calculated via a one-way ANOVA with Tukey 
analysis in Minitab (version 17.1.0).
Cell Fractionation
Prior to cell treatment, the siRNA 5’-phosphate was substituted with 32P-containing 
phosphate using polynucleotide Kinase (Fisher) and γ-32P ATP (6000 Ci/mmol) as the 
source of isotope. The KB cell medium was replaced with folic acid-free RPMI 1640 
supplemented with 10% FBS. Cells (200,000 cells/mL, 2 mL) were seeded in a 6 well plate 
(Corning Inc.). After 24 hours, cells were treated with 500 µL of a radio-labelled polymer-
siRNA complex solution. Lipofectamine 2000 (Invitrogen) was used as the positive control, 
and the Lipofectamine-siRNA complexes were prepared according to manufacturer protocol. 
The final siRNA concentration delivered was maintained at 100 nM. After 24 hours, the cell 
media was removed, and the cells were lysed with 1 mL lysing buffer (150 mM HEPES, pH 
= 8.0; 0.25% Triton X; 10% glycerol).
Linear sucrose gradients (10%-50% w/w in 25 mM Tris-HCl (pH = 7.5), 25 mM NaCl, 5 
mM MgCl2) were prepared by carefully layering 400 µL of each sucrose solution in a 
Beckman 13 × 51 mm thickwall polycarbonate tube at 0 °C. Total cell lysates were carefully 
overlaid onto the gradients and centrifuged at 36,000 rpm for 2 hrs at 4 °C in a SW 55 Ti 
rotor. Gradient fractions were then collected in 300 µL increments, and total RNA was 
precipitated into 1 ml of isopropanol, employing 1 µL glycogen solution as a co-precipitant. 
After centrifugation, the supernatant was removed, and the precipitants were suspended in 
2X RNA loading buffer from Ambion. RNA was separated on a 12% acrylamide gel 
containing 8 M urea, and visualized with ethidium bromide staining on a BioRad ChemiDoc 
MP. The gel was then electroblotted and crosslinked. The radio-labelled siRNA was imaged 
using a GE Healthcare Life Sciences Typhoon FLA-7000. The relative amount of siRNA 
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was quantified in bands corresponding to both free siRNA and that loaded in protein 
complexes using densitometry software ImageQuant.
Copolymer Cytotoxicity
The anti-proliferative activities of poly[(HPMA-stat-APMA)-block-(HPMA-stat-
DMAPMA)] copolymers were determined following a standard literature procedure. 24 
hours prior to treatment, the KB cell medium was replaced with folic acid-free RPMI 1640 
supplemented with 10% FBS. Cells (200,000 cells/mL, 100 µL) were seeded in a 96 well 
plate (Corning Inc.). Cells were treated with 50 µL of a polymer stock solution at a polymer 
concentration equivalent to that used in the gene suppression studies. Cell proliferation was 
determined via a standard MTT assay (Vybrant MTT Cell Proliferation Assay Kit; 
Invitrogen). Cells were incubated for 48 h and 72 h before adding 10 µL of a 12 mM MTT 
reagent to each well. The cells were further incubated for an additional 4 h, followed by 
adding 100 µL of a SDS (10%)/HCl (0.01 M) solution to each well. The absorbance was 
then determined utilizing a Biotek Synergy2 MultiMode Microplate Reader. All studies 
were performed in triplicate.
Characterization
All polymers were characterized by aqueous size exclusion chromatography (ASEC) with an 
eluent of 1 wt % acetic acid and 0.1 M Na2SO4 (aq) at a flow rate of 0.25 ml/min at 25 °C, 
Eprogen Inc. CATSEC columns (100, 300, and 1000 Å), a Wyatt Optilab DSP 
interferometric refractometer (λ = 690 nm), and a Wyatt DAWN-DSP multi-angle laser light 
scattering (MALLS) detector (λ = 633 nm). Absolute molecular weights and molecular 
weight distributions were calculated using Wyatt Astra (version 4) software. dn/dc 
measurements for all (co)polymers were performed utilizing a Wyatt Optilab DSP 
interferometric refractometer (λ = 690 nm) at 25 °C and Wyatt DNDC (version 5.90.03) 
software. Polymer monomer conversions were calculated by comparing the area of the 
monomeric refractive index signal at t0 to the area at tf.
Copolymer compositions were determined using a Varian MercuryPLUS 300 MHz NMR 
spectrometer in D2O utilizing a delay time of 5 s. 1H NMR was used to determine 
copolymer compositions by integration of the relative intensities of the methyne proton 
resonances of HPMA at 3.75 ppm and the dimethyl proton resonances of DMAPMA at 2.75 
ppm. The number of monomer units were calculated as n = (mol% × Mn, Exp)/MWmonomer. 
Conjugation of folic acid to the block copolymers was verified via UV-Vis spectroscopy 
using a PerkinElmer Lambda 35 spectrophotometer utilizing an average extinction 
coefficient of 8000 M−1cm−1 for free folic acid in phosphate buffter (10 mM Pi, 100 mM 
NaCl, pH = 7.4). 1H NMR was performed using a Varian MercuryPLUS 300 MHz 
spectrometer in DMSO-d6 with a delay time of 5 s. The amount of conjugated folic acid was 
estimated by integration of the methyne proton resonance of HPMA at 3.75 ppm and the 
proton resonance of folic acid at 8.64 ppm (s, PtC7H, 1 1H). These values were estimated by 
employing a Lorentzian/Gaussian line fit using MestReNova (version 6.0.2–5475).
Variable-angle dynamic light scattering (DLS) measurements of copolymer-siRNA 
complexes under aqueous conditions were performed using an incident light of 633 nm from 
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a Research Electro-Optics Model 31425 He-Ne laser operating at 35 mW. The angular 
dependence (60°-120° in 10° increments) of the autocorrelation function was determined 
with a Brookhaven Instruments BI-200SM goniometer with an Avalanche photodiode 
detector and TurboCorr autocorrelator. DLS measurements were carried out at a complex 
concentration (siRNA + block copolymer) of 1.0 mg/ml in phosphate buffer (10 mM Pi, pH 
= 7.4) at 25 °C. The mutual diffusion coefficients (Dm) were determined from the relation
in which Γ and q2 represent the decay rate of the autocorrelation function and the square of 
the scalar magnitude of the scattering vector respectively. The hydrodynamic radius (Rh) 
was then calculated from the Stokes-Einstein equation:
in which η is the solution viscosity, kB is Boltzmann’s constant, and T is the temperature in 
K. Samples were vortexed to ensure homogeneity and equilibrated for 30 min at 25 °C prior 
to measurement. To remove dust, samples were passed through a 0.45 µm Millipore filter 
(PVDF) directly into the scattering cells. Measurements were performed in triplicate.
Zeta-potential measurements were carried out at a complex concentration of 1.0 mg/ml in 
phosphate buffer (10 mM Pi, pH = 7.4) using a Malvern Zetasizer Nano ZEN3600. Samples 
were vortexed to ensure homogeneity and equilibrated for 30 min at 25 °C prior to 
measurement. To remove dust, samples were centrifuged at 14,000 RPM for 10 min. 
Measurements were performed in triplicate.
Quantification of polymer-complexed siRNA was achieved using the Agilent 2100 
Bioanalyzer platform with the Small RNA kit following manufacturer protocol. Samples 
were prepared with [siRNA] = 100 nM, N:P = 1 in RNase-free water. Samples were 
vortexed to ensure homogeneity and equilibrated for 30 min at 25 °C prior to measurement. 
The free siRNA concentration was determined from the area of the peak at ~39 s using the 
companion software. Percent complexed siRNA was calculated as 1 – [siRNA39s, complex]/
[siRNA39s, control].
All calorimetric experiments were carried out using a Calorimetric Sciences Corporation 
Nano DSC-II solution differential scanning calorimeter (DSC). Sodium cacadylate buffer 
(10 mM, pH = 7.2) was used as the running buffer. dsDNA (analog for siRNA) 
concentration was maintained at 75 µM while copolymer concentrations were adjusted to 
maintain N:P = 1. CpCalc (Version 2.1, Calorimetric Sciences Corp.) was used to subtract 
buffer-buffer scans from buffer-sample scans.
Potentiometric titration experiments were carried out using a Metrohm 848 Titrino Plus 
autotitrator. Polymer samples were prepared in 5.0 ml of 18.2 MΩ diH2O and concentrations 
were adjusted to maintain a total amine concentration (i.e. DMAPMA unit concentration) of 
1 mM. The pH of the solution was adjusted to 2.0 via the addition of 1 N HCl, followed by 
autotitration to pH = 12.0 with 0.05 N NaOH at 25 °C. For polymer-polystyrene sulfonate 
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(PSS) complex solutions, polymer stock solutions were adjusted to pH = 2.0 with 1 N HCl 
before addition to PSS stock solutions to afford neutral complexes (i.e. [DMAPMA] = [SS]) 
followed by dilution to 5.0 ml (final DMAPMA unit concentration = 1 mM). The complex 
solutions were then autotitrated to pH = 12 with 0.05 N NaOH. The degree of protonation 
(α) and degree of complexation (θ) as a function of pH for each polymer or polymer-PSS 
complex solution was determined from the titration curves according to literature 
procedure.29
The kinetics of degradation of free and complexed siRNA with Riboshredder RNase blend 
(Epicentre) were obtained by monitoring time-dependent ellipticity at λ = 212 nm utilizing a 
Jasco J-815 circular dichroism spectropolarimeter. Samples (V = 200 µL) were prepared in 
phosphate buffer (10 mM Pi, pH = 7.4) with [siRNA] = 5.0 µM. For complex solutions, the 
copolymer concentrations were adjusted to maintain N:P = 1. Samples were placed in a 400 
µL quartz cuvette (path length = 1 mm), and the initial spectra from λ = 200–320 nm were 
recorded with a scan rate of 50 nm/min, a 0.5 nm bandwidth, and a time constant of 2 s. The 
signal-to-noise was doubled for all spectra by averaging four scans. After establishing a 
baseline, 0.63 µL of Riboshredder stock solution (0.25 unit/µL diluted in 10 mM Pi, pH = 
7.4) was added followed by inversion of the cuvette to promote mixing. The ellipticities at λ 
= 212 nm were then recorded over 20 min. with a 0.5 nm bandwidth and a time constant of 2 
s.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
ASEC-MALLS of poly(HPMA-stat-APMA) macroCTA and subsequent chain extensions 
with DMAPMA and HPMA (P100-P0)
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Figure 2. 
Differential power thermograms for copolymer-dsDNA complexes. Samples shifted along Y-
axis for clarity.
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Figure 3. 
α- and θ vs. pH curves for (A) P100, (B) P75, (C) P50, (D) P25, (E) P0, and (F) P2 and 
their respective complexes with PSS
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Figure 4. 
(A) RT-qPCR analysis of down-regulation of human survivin mRNA by copolymer-siRNA 
complexes. mRNA expression normalized to Lipofectamine. (B) Corrected total 
fluorescence of siRNA labelled with AlexaFluor594 delivered via copolymer complexes. 
Samples not belonging to same letter grouping were found to have statistically significant 
variance via Tukey analysis. (C) Relative radio-labelled siRNA content after copolymer 
complex delivery and cell fractionation. Higher gradient numbers correspond to heavier 
fractions. siRNA content normalized to fraction 1 for each complex.
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Figure 5. 
(A) Molar ellipticity of siRNA before and 20 minutes after addition of Riboshredder RNase 
blend. (B) Enzymatic degradation of free and copolymer-complexed siRNA with 
Riboshredder RNase blend as monitored by the normalized disappearance of the CD band at 
212 nm.
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Scheme 1. 
Synthetic pathway for the preparation of poly[(HPMA-stat-APMA)-block-(HPMA-stat-
DMAPMA)] copolymers and subsequent complexation with siRNA.
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Table 2
The hydrodynamic radii (Rh), ζ-potential, and percent complexed siRNA for siRNA and copolymer-siRNA 
complexes
Sample Rh (nm) ζ-potential (mV) Complexed
siRNA
P100 8.3 −1.02 75.0 %
P75 11.8 −0.44 75.9 %
P50 10.7 −1.82 79.3%
P25 7.8 −0.91 75.7 %
P0 N/Aa −7.55 34.7 %
siRNA N/Aa −9.99 --
a
The excess scattering compared to solvent was too low for accurate determination.
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